Currently out of the existing stock ratings of Madison El-Saadi, 16 are a BUY (94.12%), 1 are a HOLD (5.88%).

Madison El-Saadi

Work Performance Price Targets & Ratings Chart

Analyst Madison El-Saadi, currently employed at B. RILEY, carries an average stock price target met ratio of 53% that have a potential upside of 59.26% achieved within 151 days.

Madison El-Saadi’s has documented 34 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on VNDA, Vanda Pharmaceuticals at 09-Aug-2026.

Wall Street Analyst Madison El-Saadi

Analyst best performing recommendations are on WVE (WAVE LIFE SCIENCES LTD).
The best stock recommendation documented was for WVE (WAVE LIFE SCIENCES LTD) at 9/19/2024. The price target of $11 was fulfilled within 27 days with a profit of $5.06 (85.19%) receiving and performance score of 31.55.

Average potential price target upside

AXSM Axsome Therapeutics CAPR Capricor Therapeutics ETON Eton Pharmaceuticals VNDA Vanda Pharmaceuticals WVE Wave Life Sciences Ltd

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 06-Sep-2022

$316

$101.34 (47.21%)

$306

Buy Since 24-Jan-2024

$297

$82.34 (38.36%)

$304

Buy Since 02-Sep-2025

$256

$41.34 (19.26%)

$255

Buy Since 15-Oct-2019

$275

$60.34 (28.11%)

$260

Hold Since 04-May-2026

$251

$36.34 (16.93%)

$242

Show more analysts

Please expand the browser size to see the chart

Which stock is Madison El-Saadi is most bullish on?

Potential upside of $15.9 has been obtained for WVE (WAVE LIFE SCIENCES LTD)

Which stock is Madison El-Saadi is most reserved on?

Potential downside of -$11.05 has been obtained for ETON (ETON PHARMACEUTICALS)

What Year was the first public recommendation made by Madison El-Saadi?

On 2024

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?